Fate Therapeutics Inc (NASDAQ:FATE) currently has a daily average trading volume of 1.99M but it saw 1739681 shares traded in last market. With a market cap of 131.83M USD, the company’s current market price of $1.15 came rising about 5.50 while comparing to the previous closing price of $1.09. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.92 and as low as $0.66. In the recent trading on the day, stock has struck highest price mark of $1.11 while lowest mark touched by it was $1.17.
Piper Sandler upgraded its recommendation for the stock as a “Overweight” from “Neutral” on June 17, 2024 while assigning a price target range of $4-$6. Wells Fargo issued its recommendations for the stock as it resumed the price target for the stock is $6.
Over the week, FATE’s stock price is moving 0.88% up while it is -28.12% when we observe its performance for the past one month. Year-to-date it is -63.72% down and over the past year, the stock is showing a downside performance of -30.30%.
Currently, Fate Therapeutics Inc’s total number of outstanding shares is 114.60M with 1.74% of that held by the insiders while 94.13% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -48.16% and return on equity (ROE) at -49.23%. Stock’s beta reads 2.24. Stock has a price to book (P/B) ratio of 0.46 while price to sale or P/S ratio amounts to 9.88. Its return on asset (ROA) is -36.32% on average.
